About Synchron
Synchron builds in the biotech category and is tracked by 100Xfounder for operating momentum, talent growth, and market execution.
What they do: Restore lives by deciphering the neural code of the brain Biotech Healthcare Hardware
Funding context: Khosla Ventures, $75M Series C in 2022
Recent milestones:
- Synchron appears in the 100Xfounder startup directory import feed.
Why it Matters
Synchron matters because restore lives by deciphering the neural code of the brain Biotech Healthcare Hardware
Funding Snapshot
- Series C | Khosla Ventures, $75M Series C in 2022
Hiring Roles
This company is actively hiring.
Meet the Founders
Synchron Team
Founder & CEO


